Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing.
Laura M WillemsenEline A VlotPaul W A JanssenClaire D VisserKai ZhengJohannes C KelderPeter G NoordzijErik-Jan van den DoolPatrick KleinChristian M HackengJurrien M Ten BergPublished in: Research and practice in thrombosis and haemostasis (2021)
In patients who are on aspirin preoperatively, aspirin sensitivity was associated with 12-hour blood loss after CABG, suggesting that preoperative VerifyNow aspirin testing could identify patients undergoing CABG at high risk for perioperative bleeding.
Keyphrases
- low dose
- patients undergoing
- coronary artery bypass
- antiplatelet therapy
- cardiovascular events
- percutaneous coronary intervention
- anti inflammatory drugs
- end stage renal disease
- coronary artery bypass grafting
- newly diagnosed
- acute coronary syndrome
- ejection fraction
- coronary artery disease
- cardiovascular disease
- cardiac surgery
- patient reported